Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Over the next century, vaccines virtually wiped out long-feared scourges like polio and measles and drastically reduced the ...

Many everyday symptoms are inconsequential. You have a poor night’s sleep to thank for your bloodshot eyes, or a new lotion ...

Shorter sleep duration may raise the risk for glaucoma and elevated IOP in patients with obstructive sleep apnea.

Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The ...

Biological age acceleration is associated with an increased risk of glaucoma and elevated intraocular pressure.

While working a shift in the ER, nurse Breanna T. suddenly lost her sight. Days of blurry vision, failed appointments and ...

Long-term exposure to air pollution is associated with a significantly increased risk of primary open-angle glaucoma.

With more options available than ever to treat patients with glaucoma, it has become clearer that treatment needs to occur as ...

Glaukos Q1 results beat expectations, and the company is delivering on a robust pipeline as it continues to build an ...

Table 1. Common neurodegenerative changes in glaucoma and Alzheimer's disease. Retinal amyloid-β (Aβ) is increasingly expressed in glaucoma and Alzheimer's disease (AD). Neurotoxic Aβ peptide ...